Major averages split as large-cap tech and biotech carry the tape. RTX secures up to $24.4B SM-6 interceptor contract. LLY wins FDA approval for Jaypirca as first-line CLL treatment. SAP agrees to acquire AI skills platform TechWolf. Hagens Berman investigates IBM after Q2 revenue miss. CN sets grain movement record.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
